Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

The impact of covid-19 on lung cancer care

Written by | 4 Feb 2021

Interview and article by Christine Clark. Delayed diagnoses and more patients with advanced cancers were consequences of the coronavirus pandemic, according to Dr Erin Schenk, Assistant Professor, Thoracic… read more.

Ivermectin gathers pace in Europe

Written by | 31 Jan 2021

Article written by Christine Clark. During the past week Slovakia became the first European country to give formal approval for the use of ivermectin for both prophylaxis and… read more.

Link between gut microbes, diet and illnesses

Written by | 30 Jan 2021

Diets rich in healthy and plant-based foods encourages the presence of gut microbes that are linked to a lower risk of common illnesses including heart disease, research has… read more.

Ivermectin meta-analysis – the implications

Written by | 27 Jan 2021

Interview and article by Christine Clark Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19…. read more.

Ivermectin meta-analysis – the findings

Written by | 26 Jan 2021

Interview and article by Christine Clark. Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for… read more.

Ivermectin meta-analysis – the background

Written by | 25 Jan 2021

Interview and article by Christine Clark. IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin… read more.

Why COVID-19 pneumonia lasts longer, causes more damage than typical pneumonia

Written by | 24 Jan 2021

Bacteria or viruses like influenza that cause pneumonia can spread across large regions of the lung over the course of hours.

Poor gut health connected to severe COVID-19

Written by | 22 Jan 2021

People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.

New milestone in search for leishmaniasis vaccine

Written by | 17 Jan 2021

Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

COVID-19 severity not linked to long-term problems

Written by | 16 Jan 2021

Fatigue, ill-health and breathlessness are all common following COVID-19.

Most patients with COVID-19 suffer lasting effects

Written by | 15 Jan 2021

Most people hospitalised with COVID-19 have at least one symptom six months after falling ill, according to a follow-up study of people in Wuhan China.

EU approved 96 new medicines in 2020

Written by | 14 Jan 2021

The European Medicines Agency gave its backing to 15 new medicines at its December meeting, taking its total for the year to 96.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.